12/6/2021Maximizing China Access for Innovative Therapies (PharmExec)

12/6/2021Snapshot of the 67 Novel Drug Products Included in the 2021 NRDL Thru ...

12/5/2021China Made Solid Reform and Regulatory Advances on Multiple Fronts Las...

12/5/2021Biogen's Spinraza, Fosun-Kite's Yescarta and A Controversial Alzheimer...

12/5/2021Innovent and Lilly Announce Successful Expansion of Sintilimab in Chin...

12/3/2021FDA Rejects BeyondSpring's NDA for Neutropenia Therapy

12/3/2021BeiGene and EUSA Announce CN Approval of SYLVANT (Siltuximab for Inje...

12/3/2021CDE Issues the Technical Guidelines for Long Term Follow-up Clinical R...

12/3/2021CDE Issues Two Technical Guidelines for Non-clinical Research and Asse...

12/3/2021Recent Executive Moves

12/2/2021NMPA Solicits Comments on the Draft Guidelines for Pharmacovigilance I...

12/2/2021WuXi STA and Coherent Biopharma Forms Strategic Partnership 

12/2/2021SQZ Biotech Announces Acceptance by Roche Accelerator in China

12/2/2021NHSA and MOHRSS Officially Issue the 2021 NRDL, Adding 74 and Removing...

12/1/2021Financial-related Company News in Brief

12/1/2021NMPA Issues Technical Guidelines Related to Companion Diagnostic Reag...

12/1/2021Innovent and Ascentage Granted NMPA Approval for China's First 3rd Ge...

12/1/2021Chinook Launches Chinese JV to Double Down on Kidney Disease R&D

12/1/2021Genetron and AstraZeneca China Enter Co-Development Agreement for MR...

12/1/2021Malaysia's IHH Healthcare Weighing Sale of Its $1B Chinese Hospital Bu...

12/1/2021Novo Nordisk, Sanofi and Eli Lilly Cut Insulin Prices and Lose Share i...

11/30/2021NMPA Issues the Dossier Requirements for Import and Export Permit of N...

11/30/2021NMPA Announces Package Insert Revision of Glycerol Fructose and Sodium...

11/30/2021JPO Releases Final Tender Outcome of the 6th VBP

11/30/2021Jemincare Licenses Kras Inhibitor JMKX1899 to HUYABIO 

11/30/2021Clover Gets Another $36.9M from CEPI for Covid-19 Vaccine Development

11/30/2021Changes in Notifiable Infectious Disease Incidence in China during the...

11/30/2021Adagene Gains U.S. IND Approval for P1b/2 Trial of Anti-CTLA-4 mAb A...

11/30/2021Nicholas Hall Reports Growth of Chinese OTC Dermatologicals Market in ...

11/30/2021NH's DB6: Pandemic Continues to Dictate CHC Trends with China Recoveri...

Page:158/774 Total number of articles:23207: [First][<<] [156] [157] [158] [159] [160] [>>] [End]